Conditions: Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 339
Healthy volunteers: no

Brief summary:
This study will compare insulin lispro protamine suspension (ILPS) and insulin glargine in combination with the patient's oral diabetes medications and exenatide, for their ability to control blood sugar in patients with type 2 diabetes.

Detailed description:

Arms:
arm 1: Insulin Lispro Protamine Suspension (ILPS) arm 2: Insulin Glargine

Interventions: intervention 1: Insulin Lispro Protamine Suspension intervention 2: Insulin Glargine
Intervention descriptions: intervention 1: Administered subcutaneously once a day at bedtime intervention 2: Administered subcutaneously once a day at bedtime

Protocol document: